Clinical Study
Interleukin-6 and Vitamin D Status during High-Intensity Resistance Training in Patients with Chronic Kidney Disease
Table 2
Baseline characteristics of the participants.
| | Parameter | Initial cohort |
| | Age (years) | 54 ± 2 | | Gender (f/m) | 15/21 | | Duration of chronic dialysis (years) | 5.4 ± 0.9 | | Dialysis modality (HD/PD) | 30/6 | | Body mass index (kg/m2) | 25.0 ± 0.9 | | Albumin (g/L) | 41.2 ± 0.6 | | Haemoglobin (mmol/L) | 7.4 ± 0.2 | | C-reactive protein (mg/L) | 7.2 ± 1.2 | | Bicarbonate (mmol/L) | 25.7 ± 0.6 | | Comorbidities (score 0–3) | 2.3 ± 0.1 | | Primary renal disease | | | T2DM | 1 | | Hypertension | 4 | | Polycystic | 8 | | Glomerulonephritis | 14 | | Nephrosclerosis | 2 | | Other/unknown | 6 | | Interleukin-6 (pg/mL) | 8.6 ± 1.3 | | 1,25-OH2 D (pmol/L) | 31.4 ± 1.8 | | 25-OH D (nmol/L) | 60.3 ± 6.0 | | Normal vitamin D, 25-OH D ≥ 50 nmol/L | 49% () | | Mild vitamin D deficiency, 25-OH D 25–50 nmol/L | 34% () | | Moderate vitamin D deficiency, 25-OH D 12.5–25 nmol/L | 14% () | | Severe vitamin D deficiency, 25-OH D < 12.5 nmol/L | 3% () |
|
|
F: female; M: male; HD: haemodialysis; PD: peritoneal dialysis. Data are presented as the mean ± SEM, count, or as a percentage.
|
